Biotech

All Articles

Biogen, UCB report phase 3 lupus win after stopping working earlier trial

.Biogen and UCB's depend developing right into phase 3 on the back of a failed research study looks ...

Aptadir hopes brand-new RNA preventions may reverse difficult cancers cells

.Italian biotech Aptadir Rehabs has released with the pledge that its own pipe of preclinical RNA pr...

Wave surfs DMD success to regulators' doors, delivering stockpile

.Surge Lifestyle Sciences has met its own objective in a Duchenne muscular dystrophy (DMD) study, pl...

Sanofi tweezes brand new CSO coming from in-stealth biotech

.After a handful of years in biotech, Mike Quigley, Ph.D., is coming back to the pharma fold, using ...

Achilles trickles tissue treatment system, prepares for unemployments after missing 'commercial viability' targets

.Achilles Therapies has wrecked its strategy. The English biotech is actually stopping work on its c...

Aligos proclaims period 2 MASH win, reducing liver excess fat as much as 46%

.Aligos Therapies is actually advertising a midstage succeed in metabolic-dysfunction associated ste...

Basilea scores $268M BARDA backing for antifungals, anti-biotics

.Basilea Pharmaceutica's job developing new antifungals has acquired a considerable increase from th...

Capricor markets Europe rights to late-stage DMD treatment for $35M

.Possessing currently gathered up the USA rights to Capricor Therapies' late-stage Duchenne muscle d...

FDA fragments adcomm for Applied's unusual health condition drug

.After dismissing the decision date for Applied Therapeutics' metabolic condition medicine govoresta...

Novo inks $600M NanoVation package to examine hereditary medications ex-liver

.Novo Nordisk is actually proceeding its own push in to genetic medications, accepting pay NanoVatio...